Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Rick Steves Doesn't Want You Overlooking This Food Spot While In France - 2How to track NASA’s Artemis II and Orion’s journey to the moon
- 3Scientists train to dive beneath polar ice as climate change warms the Arctic and Antarctica
- 4Vote In favor of Your Favored Web-based Venture Stage
- 5A red meat allergy from tick bites is spreading – and the lone star tick isn’t the only alpha-gal carrier to worry about
- Why do people get headaches and migraines? A child neurologist explains the science of head pain and how to treat it
- Scientists solve the mystery of the prehistoric 'Burtele Foot'
- Auschwitz Committee wants German auction of Holocaust items scrapped
- At UN climate conference, some activists and scientists want more talk on reforming agriculture
- The Drone Video of the Year is stunning – you've not seen Namibia like this
- NASA astronauts take new moonsuit for a swim | Space photo of the day for Nov. 28, 2025
- Electric Vehicles for Eco-Accommodating Driving
- Best Streaming Gadget for Your Home Theater
- The Best Games On the planet
